| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/02/1997 | EP0765357A1 Antiviral dendrimers |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765333A1 Quillaja saponin adjuvant and vaccine formulation containing same |
| 04/02/1997 | EP0765329A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765170A1 Composition for inducing a mucosal immune response |
| 04/02/1997 | EP0765165A1 Constrained peptides |
| 04/02/1997 | EP0765151A1 Antibacterial oil-in-water emulsions |
| 04/02/1997 | EP0741728A4 Improved process for synthesizing carbapenem intermediates |
| 04/02/1997 | EP0680482B1 Process for the manufacture of a tricyclic compound |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0507851B1 Quinolone carboxylic acid--metal ion--acid complexes |
| 04/02/1997 | EP0495008B1 Vaccine conjugate for treatment of avian diseases |
| 04/02/1997 | CN1146782A Enzymatic antimicrobial compositions |
| 04/02/1997 | CN1146768A Process for making an epoxide |
| 04/02/1997 | CN1146725A Gel for treatment of skin diseases and for disinfection of the skin |
| 04/02/1997 | CN1146724A Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 04/02/1997 | CN1146359A Feijiwan pill (for lung disease) and preparation method |
| 04/02/1997 | CN1146338A Stable cross-linked compound of polyvinyl pyrrolidone and iodine and method for preparation of said compound |
| 04/01/1997 | US5616724 Fused pyrrolo[2,3-c]carbazole-6-ones |
| 04/01/1997 | US5616703 Separation of cephalosporin isomers |
| 04/01/1997 | US5616612 Therapy for cancer, aids, anemia, infections |
| 04/01/1997 | US5616564 Antiparasitic oligonucleotides active against drug resistant malaria |
| 04/01/1997 | US5616559 Genetic engineered polypeptide viricides inhibiting virus transcription and replication |
| 04/01/1997 | US5616554 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 04/01/1997 | US5616327 M-protein peptides of influenza virus as antiviral agents |
| 04/01/1997 | CA1339033C Glycopeptide antibiotics a82846 from nocardia orientalis |
| 03/30/1997 | CA2186650A1 13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and others pests |
| 03/27/1997 | WO1997011093A2 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | WO1997011087A1 L-nucleoside dimer compounds and therapeutic uses |
| 03/27/1997 | WO1997011068A1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient |
| 03/27/1997 | WO1997010844A1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010834A1 Bioactive factors of aloe vera plants |
| 03/27/1997 | WO1997010806A1 Aerosol compositions |
| 03/27/1997 | WO1997005873A3 Use of fluconazole for inhibiting the growth of cancers |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | WO1996040728A3 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 03/27/1997 | CA2232515A1 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | CA2206878A1 L-nucleoside dimer compounds and therapeutic uses |
| 03/26/1997 | EP0764445A2 Acellular vaccine |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764161A1 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 03/26/1997 | EP0764160A1 Thiopyridines for use in the control of helicobacter bacteria |
| 03/26/1997 | EP0764028A2 Method of treating retained pulmonary secretions |
| 03/26/1997 | EP0764023A1 Compounds and compositions for administration via oral inhalation or insufflation |
| 03/26/1997 | EP0611373B1 Oligo-2'-deoxynucleotides and their use as drugs with an antiviral action |
| 03/26/1997 | EP0539493B1 Targeted drug delivery via phosphonate derivatives |
| 03/26/1997 | EP0535067B1 Endonucleases |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146201A Sulphonamide derivatives as aspartyl protease inhibitors |
| 03/26/1997 | CN1146154A Use of dimeticone for local antibacterial therapy and/or prevention and therapy of helicobacter phylori (HP) associated syndromes and infectious diseases |
| 03/26/1997 | CN1146136A Targeted cytolysis of HIV-infected cells by Chimeric CD4 receptor bearing cells |
| 03/26/1997 | CN1145906A Process for production of pharmaceutically acceptable salt of alavulanic acid |
| 03/26/1997 | CN1145903A D4T polymorphic form I process |
| 03/26/1997 | CN1145779A Medicine matrix and its use |
| 03/26/1997 | CN1034332C Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and method of producing them |
| 03/26/1997 | CN1034329C Prepn. of novel substituted propargyl zazcyclobutanone |
| 03/25/1997 | US5614652 Cytotoxic, palladium disposed within an iron oxide matrix |
| 03/25/1997 | US5614623 Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate and processes for their preparation |
| 03/25/1997 | US5614621 Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents |
| 03/25/1997 | US5614618 Origin of replication complex genes |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614614 Antibiotics, chemical intermediates |
| 03/25/1997 | US5614559 Compound for inhibiting HIV infectivity |
| 03/25/1997 | US5614551 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 03/25/1997 | US5614535 Adhesion receptor antagonists |
| 03/25/1997 | US5614534 Derivatives of β, β-dimethyl-4-piperidineethanamine as inhibitors of the cholesterol biosynthesis |
| 03/25/1997 | US5614384 Hepatitis B virus surface proteins with reduced host carbohydrate content |
| 03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
| 03/25/1997 | US5614199 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic β-cyclodextrin derivatives, a process for the preparation thereof and the use thereof |
| 03/25/1997 | CA2080040C Methods for preventing mycobacterial infections by administration of rifabutin |
| 03/25/1997 | CA2067178C Solid tumor treatment method and composition |
| 03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
| 03/25/1997 | CA1339008C Amphotericin b liposome preparation |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010263A1 Actinomycin d analogues |
| 03/20/1997 | WO1997010235A1 5-AMIDOMETHYL α, β-SATURATED AND -UNSATURATED 3-ARYL BUTYROLACTONE ANTIBACTERIAL AGENTS |
| 03/20/1997 | WO1997010223A1 Aminoaryl oxazolidinone n-oxides |
| 03/20/1997 | WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
| 03/20/1997 | WO1997010205A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 03/20/1997 | WO1997010002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | WO1997010001A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | WO1997010000A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | WO1997009999A1 Methods and compositions for treatment of hsv-2 infections and conditions |
| 03/20/1997 | WO1997009994A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | WO1997009980A1 Pharmaceutical formulations containing darifenacin |
| 03/20/1997 | WO1997003187A3 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 03/20/1997 | CA2232048A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | CA2232033A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | CA2232002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | CA2231998A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | CA2231996A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/19/1997 | EP0763537A2 Non-peptidyl Ras farnesyl transferase inhibitors |
| 03/19/1997 | EP0763362A2 A pharmaceutical base in ointment form and its use |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |